These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8344127)

  • 1. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
    Samuelsson U; Ludvigsson J; Sundkvist G
    Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
    Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
    Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
    Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.
    Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP
    Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population.
    Gürlek A; Erbaş T; Sayinalp S; Gedik O
    Acta Diabetol; 1996 Sep; 33(3):216-9. PubMed ID: 8904928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of predictors of beta-cell survival in type I diabetes.
    Schiffrin A; Suissa S; Poussier P; Guttmann R; Weitzner G
    Diabetes; 1988 Jul; 37(7):920-5. PubMed ID: 3290010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus.
    Warnock GL; Kneteman NM; Ryan EA; Rabinovitch A; Rajotte RV
    Diabetologia; 1992 Jan; 35(1):89-95. PubMed ID: 1541386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.